Skip to content

A clinical study on Ayurvedic management of Sciatica(Gridhrasi) using Rasnadi guggul and Vatari Guggul.

An open Randomized comparative clinical study of Rasnadi Guggul and Vatari Guggul in the management of Gridhrasi - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/103599
Enrollment
156
Registered
2026-02-11
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M958- Other specified acquired deformities of musculoskeletal system

Interventions

None listed

Sponsors

Quadra institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 patients who have signed the informed consent 2 Duration of illness upto 2years 3 Radiating pain, starting from the gluteal region towards the foot. 4 Tenderness of the Sciatica Nerve course 5 Severe pain in squatting 6 sensory changes 7 Positive Straight leg test

Exclusion criteria

Exclusion criteria: Duration of disease more than 2 years Monoplegia Paraplegia Hip joint arthritis T.B. Spine/Hip Traumatic lesion in lumbo-sacral region Known case of Pelvic inflammatory disease Conceiving female Patients with co-morbidities such as HTN, DM, Thyroid and H.I.V Ankylosing Spondylosis No involvement of urinary bladder and rectum

Design outcomes

Primary

MeasureTime frame
To assess the effect of both these drugs by noting down the changes in various subjective parameters that are considered for the studyTimepoint: Follow up/patient will be assessed on the following days: 1.14th Day 2.28th Day Period of study 28 days.

Secondary

MeasureTime frame
To compare & analyse the effect of Vatari Guggul & Rasnadi Guggul statistically to meet the aim of the study To study the etiopathogenesis of Gridhrasi in Ayurvedic & Modern aspects Any new theoretical & practical concept,if found will be noted downTimepoint: Follow up/patient will be assessed on the following days: 14th Day 28th Day The period of study will be for 28 days.

Countries

India

Contacts

Public ContactDr hemant Paradkar

A.P.M.s Ayurved Mahavidyalaya,Sion,Mumbai

hemant.paradkar@gmail.com9987519315

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026